GLP-1s boosts pharma R&D projected return on investment: Deloitte
Companies looking to compete in the GLP-1 market are adding value to the R&D spend across the pharma sector.
Companies looking to compete in the GLP-1 market are adding value to the R&D spend across the pharma sector.